115 related articles for article (PubMed ID: 36349894)
1. Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma.
Shen CY; Chang WH; Chen YJ; Weng CW; Regmi P; Kier MKK; Su KY; Chang GC; Chen JS; Chen YJ; Yu SL
J Proteome Res; 2023 Apr; 22(4):1056-1070. PubMed ID: 36349894
[TBL] [Abstract][Full Text] [Related]
2.
Liu L; Wang C; Li S; Qu Y; Xue P; Ma Z; Zhang X; Bai H; Wang J
Front Immunol; 2021; 12():677169. PubMed ID: 34354701
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
4. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
5. Identification of Grb2-associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma.
Wang N; Zhou X; Wang X; Zhu X
J Biochem Mol Toxicol; 2022 Oct; 36(10):e23166. PubMed ID: 35822560
[TBL] [Abstract][Full Text] [Related]
6. Mast cell-based molecular subtypes and signature associated with clinical outcome in early-stage lung adenocarcinoma.
Bao X; Shi R; Zhao T; Wang Y
Mol Oncol; 2020 May; 14(5):917-932. PubMed ID: 32175651
[TBL] [Abstract][Full Text] [Related]
7. SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
Yuan L; Wu X; Zhang L; Yang M; Wang X; Huang W; Pan H; Wu Y; Huang J; Liang W; Li J; Zhu X; Wang S; Guan J; Liu L
Cancer Immunol Immunother; 2022 Feb; 71(2):399-415. PubMed ID: 34181042
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
9. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
[TBL] [Abstract][Full Text] [Related]
10.
Liu J; Han X; Chen L; Han D; Mu X; Hu X; Wu H; Wu H; Liu W; Zhao Y
Aging (Albany NY); 2020 Oct; 12(20):20308-20331. PubMed ID: 33091876
[TBL] [Abstract][Full Text] [Related]
11. Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
Tan Q; Huang Y; Deng K; Lu M; Wang L; Rong Z; Zhao W; Li S; Xu Z; Fan L; Li K; Li Z
J Cell Biochem; 2020 Nov; 121(11):4569-4579. PubMed ID: 32030808
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Zhang Y; Fu F; Zhang Q; Li L; Liu H; Deng C; Xue Q; Zhao Y; Sun W; Han H; Gao Z; Guo C; Zheng Q; Hu H; Sun Y; Li Y; Ding C; Chen H
Cell Rep Med; 2024 Jan; 5(1):101358. PubMed ID: 38183982
[TBL] [Abstract][Full Text] [Related]
13. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression.
Chen YJ; Roumeliotis TI; Chang YH; Chen CT; Han CL; Lin MH; Chen HW; Chang GC; Chang YL; Wu CT; Lin MW; Hsieh MS; Wang YT; Chen YR; Jonassen I; Ghavidel FZ; Lin ZS; Lin KT; Chen CW; Sheu PY; Hung CT; Huang KC; Yang HC; Lin PY; Yen TC; Lin YW; Wang JH; Raghav L; Lin CY; Chen YS; Wu PS; Lai CT; Weng SH; Su KY; Chang WH; Tsai PY; Robles AI; Rodriguez H; Hsiao YJ; Chang WH; Sung TY; Chen JS; Yu SL; Choudhary JS; Chen HY; Yang PC; Chen YJ
Cell; 2020 Jul; 182(1):226-244.e17. PubMed ID: 32649875
[TBL] [Abstract][Full Text] [Related]
15. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
16. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.
Zhang W; Li Y; Lyu J; Shi F; Kong Y; Sheng C; Wang S; Wang Q
Cancer Sci; 2022 Mar; 113(3):891-903. PubMed ID: 34967077
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
Tao Y; Li Y; Liang B
Future Oncol; 2020 Aug; 16(24):1825-1837. PubMed ID: 32501723
[No Abstract] [Full Text] [Related]
18. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma.
Jin X; Zhou H; Song J; Cui H; Luo Y; Jiang H
Comput Math Methods Med; 2021; 2021():9971353. PubMed ID: 34257701
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the immune cell infiltration landscape in lung adenocarcinoma.
Ou HB; Wei Y; Liu Y; Zhou FX; Zhou YF
Arch Biochem Biophys; 2022 May; 721():109168. PubMed ID: 35346643
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
